Source: International Congress 2015 – Asthma mechanisms and management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Mandy Menzel (Lund, Sweden), Mandy Menzel, Hamid Akbarshahi, Lena Uller. Azithromycin exhibits interferon-inducing properties in an experimental mouse model of asthma exacerbation. Eur Respir J 2015; 46: Suppl. 59, 5095

Member's Comments

No comment yet.

Related content which might interest you: CompEx – A novel composite asthma exacerbation endpoint Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD Year: 2015 Effect of roflumilast on airway remodeling in a murine model of chronic asthma Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Roflumilast but not dexamethasone or fluticasone reduces neutrophilic airway inflammation and hyperreactivity in a murine influenza-induced asthma exacerbation model Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Evaluation of methotrexate in the treatment of severe asthma Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Asthma control, symptoms and exacerbations across treatment levels in patients with asthma Source: Annual Congress 2013 –Management of respiratory diseases in primary care Year: 2013 Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment? Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Achievement of asthma control in patients with cold airway hyperresponsiveness at different variants of basic therapy Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in the mouse Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD Year: 2013 Study of antioxidant use in patients with asthma exacerbations Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016 Investigating antioxidant therapy for steroid-resistant asthma Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 Establishment of a murine asthma exacerbation model by combining OVA exposure with either RSV or influenza infection Source: International Congress 2016 – Immune responses in the lung Year: 2016 Acute exacerbations of asthma in Barcelona, the recent experience Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013 Characterization of asthma exacerbations in outpatients – National survey Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Small airways targeting of inhaled steroids for severe therapy resistant asthma in children Source: International Congress 2015 – Paediatric asthma and allergy: asthma management Year: 2015 Sesonal variations of severe asthma exacerbations in the US Source: International Congress 2014 – Risk factors for respiratory disease Year: 2014 Comparison of clinical features of severe persistent asthma and refractory asthma Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 Predictors of exacerbations in asthma Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 The ’real-life’ long-term efficacy of omalizumab in severe persistent IgE-mediated allergic asthma in Malta Source: International Congress 2016 – Asthma management Year: 2016